2016 American Transplant Congress
Clinical Rejection-Risk Assessment with Allospecific CD154+T-Cytotoxic Memory Cells (CD154+TcM) After Pediatric Liver or Intestine Transplantation (LTx, ITx).
Surgery, Children's Hosp of Pgh of UPMC & Univ of Pittsburgh, Pittsburgh, PA.
Background: In preclinical evaluation, CD154+TcM predict acute cellular rejection after LTx or ITx with sensitivity/specificity of 80%. Purpose/Methods: To summarize test indications and performance during…2016 American Transplant Congress
Clinical Analysis of Patients with Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.
Surgery, Seoul St. Mary's Hospital, Catholic University, Seoul, Korea.
Purpose: For living-donor liver transplantation (LDLT), there has been a tendency to accept extended criteria in comparison with deceased-donor liver transplantation (DDLT). However, HCC recurrence…2016 American Transplant Congress
Updated Experience of Living Donor Right Hepatectomy Using Mini-Incision Technique.
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI.
Aim: We previously reported 28 consecutive cases of minimally invasive living donor right hepatectomy (10cm mini-incision right hepatectomy with or without laparoscopic assistance). Currently, we…2016 American Transplant Congress
Basiliximab Induction for Safe Delay of Calcineurin Inhibitors in High MELD Liver Transplant Recipients.
Background: Available literature supports basiliximab induction for safe delay of CNI initiation and renal recovery; however there is a paucity of evidence for use in…2016 American Transplant Congress
A Call for a New Paradigm of Organ Allocation within the Confines of MELD for Those Who Are Not “the Sickest”.
Comprehensive Transplant Center, Northwestern University, Chicago, IL.
BACKGROUND: Liver Allocation policy in the United States is in dynamic flux, with revisions in policy reflecting designs to optimize access to and outcomes for…2016 American Transplant Congress
Utilization of Parenteral Nutrition in Patients Undergoing Liver Transplantation.
1Houston Methodist Hospital, Houston; 2Kendall Regional Medical Center, Miami.
Introduction: Protein-calorie malnutrition is common in patients with advanced liver disease and is a risk factor for poor outcomes after liver transplantation (LT). Perioperative parenteral…2016 American Transplant Congress
The Use of Thromboelastography (TEG) in Preoperative Pediatric Liver Transplantation to Predict Postoperative Thrombotic Complications.
Introduction: Little data exists in the use of thromboelastography (TEG) in pediatric liver transplantation. In 2011 we implemented pre-transplant TEGs for patients listed for liver…2016 American Transplant Congress
Pre-Transplant Risk Factors: Predicting Nonadherence and Rejection in Adult Liver Transplant Recipients.
Purpose: The pre-liver transplant (LT) psychosocial evaluation aims to identify risk factors for immunosuppression nonadherence (NA) and poor post-LT outcomes. Despite broad support for these…2016 American Transplant Congress
Use of the Psychosocial Assessment Tool to Identify Risk in Families of Pediatric Liver Transplant Recipients.
Pediatrics, University of Michigan, Ann Arbor, MI.
Purpose: Although families of pediatric liver transplant recipients have documented psychosocial needs, the systematic identification of needs and delivery of evidence-based care remain challenging. This…2016 American Transplant Congress
Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.
Mulit-Organ Transplant Institute, Ochsner Medical Center, New Orleans, LA.
Background: Hepatitis C (HCV) is the most common indication for liver transplant in the United States representing more than 40% of all recipients. Availability of…
- « Previous Page
- 1
- …
- 156
- 157
- 158
- 159
- 160
- …
- 180
- Next Page »